EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Network‐based precision medicine and systems pharmacology

Arvind K Pandey, Susan Dina Ghiassian, Joseph Loscalzo

British Journal of Pharmacology · 2026

DOI: 10.1111/bph.70184 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Pharmacology, 2026. Verfasst von Arvind K Pandey und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Precision Medicine, Network Pharmacology. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Heart Association, NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The growth in detailed multi‐omic profiling has created new opportunities to tailor clinical care and therapy to patient‐level variations in disease phenotype. However, efforts towards precision medicine and personalised therapeutics are hampered by limitations in identifying biologically relevant signals that correlate with and underlie disease activity and therapeutic response from these growing arrays of data. These complexities are accentuated further when attempting to translate the new insights in disease pathobiology into new drug targets for treatment. Additionally, understanding how best to reposition existing drugs in the context of new data on disease pathogenesis remains a challenge. Network medicine provides one approach to comprehend these large data sets and identify better the key molecular and phenotypic signals that can function as disease and treatment biomarkers and that can be targeted for therapy. In this review, we discuss basic concepts in the application of network science to biological systems and then build on these concepts to discuss network‐based approaches for identifying novel disease biomarkers, elucidating new drug targets and repositioning existing drugs for new indications. LINKED ARTICLES This article is part of a themed issue Network Medicine and Systems Pharmacology. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v183.8/issuetoc

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineNetwork PharmacologyHumansAnimalsBiomarkers

Stichwörter der Autor:innen

biomarkersdrug repurposingnetwork medicinenetwork pharmacology

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Scipher Medicine Corporation, Waltham, Massachusetts, USA.

Förderung

  • American Heart Association
  • NIH HHS
  • NHLBI NIH HHS
  • National Institutes of Health

Zitieren

APA

Pandey, A. K., Ghiassian, S. D., & Loscalzo, J. (2026). Network‐based precision medicine and systems pharmacology. British Journal of Pharmacology. https://doi.org/10.1111/bph.70184

Vancouver

Pandey AK, Ghiassian SD, Loscalzo J. Network‐based precision medicine and systems pharmacology. British Journal of Pharmacology. 2026. doi:10.1111/bph.70184

BibTeX
@article{Pandey2026,
  author = {Pandey, Arvind K and Ghiassian, Susan Dina and Loscalzo, Joseph},
  title = {Network‐based precision medicine and systems pharmacology},
  journal = {British Journal of Pharmacology},
  year = {2026},
  doi = {10.1111/bph.70184}
}
Kostenlos starten →